Results 11 to 20 of about 16,111 (225)

Candida auris: a Review of the Literature [PDF]

Clinical Microbiology Reviews, 2018
SUMMARY The emerging pathogen Candida auris has been associated with nosocomial outbreaks on five continents. Genetic analysis indicates the simultaneous emergence of separate clades of this organism in different geographical locations.
Anna Jeffery-Smith, Surabhi K Taori, Silke Schelenz   +2 more
exaly   +3 more sources

Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry [PDF]

Journal of Fungi, 2019
Candida auris has emerged globally as a multidrug-resistant fungal pathogen. Isolates of C. auris are reported to be misidentified as Candida haemulonii. The aim of the study was to compare the heat production profiles of C.
Mariagrazia Di Luca, Anna Koliszak, Svetlana Karbysheva, Anuradha Chowdhary, Jacques F. Meis, Andrej Trampuz   +5 more
doaj   +3 more sources

Candida auris

Nursing
Abstract: Candida auris (C. auris) is a human pathogen that can colonize the skin and various body sites without signs or symptoms or cause serious invasive infections with high mortality. The number of cases involving drug-resistant C. auris infections have increased in the US in recent years.
Jenks JD, Tobin EH, Zahra F.
europepmc   +5 more sources

Biocide Response of Candida auris. [PDF]

Mycoses
ABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence.
Erganis S, Ozturk A, Sahin EA, Kalkanci A.   +3 more
europepmc   +2 more sources

Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?

Frontiers in Microbiology, 2018
Candida auris has emerged globally as a multidrug-resistant (MDR) medical care-associated fungal pathogen. Recent reports have demonstrated that C. auris usually expresses fewer virulence factors than does Candida albicans.
Luana Rossato, Arnaldo Lopès Colombo
exaly   +3 more sources

Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa [PDF]

Emerging Infectious Diseases
The COVID-19 pandemic coincided with rising secondary bloodstream infections (BSIs) from multidrug-resistant organisms, including Candida auris. To assess candidemia trends, we conducted a retrospective analysis of blood culture isolates from public and
Husna Ismail, Olga Perovic, Ruth Mpembe, Warren Lowman, Chetna Govind, Pieter Ekermans, Waasila Jassat, Richard Welch, Nelesh P. Govender   +8 more
doaj   +2 more sources

Emergence of highly resistant Candida auris in the United Arab Emirates: a retrospective analysis of evolving national trends [PDF]

Frontiers in Public Health
IntroductionThe Centers for Disease Prevention and Control lists Candida auris, given its global emergence, multidrug resistance, high mortality, and persistent transmissions in health care settings as one of five urgent threats.
Jens Thomsen, Jens Thomsen, Najiba M. Abdulrazzaq, Abderrahim Oulhaj, Peter S. Nyasulu, Adnan Alatoom, David W. Denning, Fatima Al Dhaheri, the UAE AMR Surveillance Consortium, Godfred Antony Menezes, Carole Ayoub Moubareck, Abiola Senok, Abiola Senok, Dean B. Everett, Dean B. Everett, Dean B. Everett   +15 more
doaj   +3 more sources

Candida auris: Epidemiology and Antifungal Strategy

Annual Review of Medicine
Candida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare
Jeniel E Nett
exaly   +3 more sources

The Second Case of Candida auris Candidemia from Turkey: An Impending Threat to the Global Health

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2021
Candida auris is a rapidly emerging fungus, which is considered globally a cause of concern for public health. This report describes Turkey’s second case of Candida auris fungemia from a tertiary care hospital in İstanbul.
Leyla TEKE, Elif SARGIN ALTUNOK, Döndü GENÇ MORALAR   +2 more
doaj   +1 more source

Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study

BMC Infectious Diseases, 2021
Background Candida auris infections are an emerging global threat with poor clinical outcome, high mortality rate, high transmission rate and outbreak potential.
Dipu Thareparambil Sathyapalan, Remya Antony, Vrinda Nampoothiri, Anil Kumar, Nandita Shashindran, Jini James, Jisha Thomas, Preetha Prasanna, Akkulath Sangita Sudhir, Jeslyn Mary Philip, Fabia Edathadathil, Binny Prabhu, Sanjeev Singh, Merlin Moni   +13 more
doaj   +1 more source